Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 286636011000036118 | metformin hydrochloride 500 mg + rosiglitazone 4 mg tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 286638011000036119 | rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet | Is a | rosiglitazone 4 mg tablet | true | Inferred relationship | Some | ||
| rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet | Is a | rosiglitazone + metformin | true | Inferred relationship | Some | ||
| rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet | has intended active ingredient | metformin | true | Inferred relationship | Some | 80022032 | |
| rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet | has Australian BoSS | metformin hydrochloride | true | Inferred relationship | Some | 80022032 | |
| rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet | has intended active ingredient | rosiglitazone | true | Inferred relationship | Some | 377973548 | |
| rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet | has Australian BoSS | rosiglitazone | true | Inferred relationship | Some | 377973548 | |
| rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 377973549 | |
| rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet | Is a | metformin hydrochloride 500 mg tablet | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet, 28 | has MPUU | True | rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet | Inferred relationship | Some | 1 |
| rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet, 112 | has MPUU | True | rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet | Inferred relationship | Some | 1 |
| rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet, 14 | has MPUU | True | rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet | Inferred relationship | Some | 1 |
| Avandamet 4/500 tablet | Is a | True | rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet | Inferred relationship | Some | |
| rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet, 56 | has MPUU | True | rosiglitazone 4 mg + metformin hydrochloride 500 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR